Refine
Is part of the Bibliography
- yes (424)
Year of publication
Document Type
- Journal article (224)
- Doctoral Thesis (195)
- Conference Proceeding (3)
- Book (1)
- Preprint (1)
Keywords
- Virologie (37)
- HIV (33)
- Masernvirus (29)
- T-Lymphozyt (24)
- measles virus (22)
- Immunologie (18)
- T cells (16)
- Dendritische Zelle (15)
- Masern (14)
- Apoptosis (13)
- dendritic cells (13)
- regulatory T cells (12)
- HIV-Infektion (11)
- Ratte (11)
- SARS-CoV-2 (11)
- Spumaviren (11)
- Immunsuppression (10)
- measles (10)
- Apoptose (8)
- CD28 (8)
- apoptosis (8)
- Antigen CD8 (7)
- B-Lymphozyt (7)
- Lymphozyt (7)
- Maus (7)
- rat (7)
- Antigen CD28 (6)
- Blimp-1 (6)
- Coronaviren (6)
- Immunaktivierung (6)
- Immunreaktion (6)
- Interferon (6)
- Retroviren (6)
- Signaltransduktion (6)
- Virusinfektion (6)
- autoimmunity (6)
- foamy virus (6)
- immunosuppression (6)
- AIDS (5)
- Autoimmunität (5)
- Gentherapie (5)
- Glucocorticosteroide (5)
- Immunsystem (5)
- Infektion (5)
- Regulatorischer T-Lymphozyt (5)
- T-Zellen (5)
- Treg (5)
- Virus (5)
- ceramide (5)
- immune evasion (5)
- interferon (5)
- Antikörper (4)
- CD150 (4)
- CD1d (4)
- COVID-19 (4)
- Dendritische Zellen (4)
- EAE (4)
- Encephalitis (4)
- Foamyviren (4)
- Immunisierung (4)
- Immuntoleranz (4)
- Impfung (4)
- Medizin (4)
- Multiple Sklerose (4)
- Polymerase-Kettenreaktion (4)
- Prednisolon (4)
- Prion (4)
- T cell (4)
- T cell receptor (4)
- T-Zelle (4)
- Tansania (4)
- Tiermodell (4)
- Toleranz (4)
- Vektor <Genetik> (4)
- Viren (4)
- cell staining (4)
- ceramides (4)
- dendritic cell (4)
- infection (4)
- macrophages (4)
- monocytes (4)
- multiple sclerosis (4)
- regulatorische T-Zellen (4)
- reverse transcriptase (4)
- sphingolipids (4)
- sphingomyelinase (4)
- tolerance (4)
- virus (4)
- APOBEC3G (3)
- Adenoviren (3)
- Affenimmundefizienzvirus (3)
- Aktivierung <Physiologie> (3)
- Antigen CD22 (3)
- Avidität (3)
- B-Zellen (3)
- CD22 (3)
- Candida albicans (3)
- Ceramid (3)
- Coronavirus (3)
- Dendritic cells (3)
- Foamyvirus (3)
- GFAP (3)
- Genexpression (3)
- HIV-1 (3)
- Immunmodulation (3)
- Immunology (3)
- Interferon <gamma-> (3)
- Interleukin 2 (3)
- Kostimulation (3)
- Monoklonaler Antikörper (3)
- Parkinson (3)
- Parkinson’s disease (3)
- Pathogenese (3)
- Polyomaviren (3)
- Prionprotein (3)
- Proliferation (3)
- RNS (3)
- RNS-Interferenz (3)
- Replikation (3)
- Resistenz (3)
- South Africa (3)
- Sphingomyelinphosphodiesterase (3)
- T cell activation (3)
- TNF-alpha (3)
- Tanzania (3)
- Toll-like-Rezeptoren (3)
- Tumor-Nekrose-Faktor <alpha> (3)
- acid sphingomyelinase (3)
- antibodies (3)
- antiretroviral therapy (3)
- encephalitis (3)
- evolution (3)
- flow cytometry (3)
- foamyvirus (3)
- gene expression (3)
- gene therapy (3)
- herpesvirus (3)
- human (3)
- immune activation (3)
- immunology (3)
- neuroprotection (3)
- phosphoantigen (3)
- phylogenetic analysis (3)
- prion protein (3)
- regulatorische T Zellen (3)
- replication (3)
- sphingosine-1-phosphate (3)
- virology (3)
- 3D tissue model (2)
- A1 (2)
- Antigen CD4 (2)
- Atemwegsinfektion (2)
- Autoantikörper (2)
- Autoimmunerkrankung (2)
- Autoimmunity (2)
- B cells (2)
- B-cell (2)
- BTN3 (2)
- Baumwollratte (2)
- Bcl-2 (2)
- Bcl-2 Familie (2)
- Bcl-2 family (2)
- Behandlung (2)
- CD28 Superagonist (2)
- CD28 superagonist (2)
- CD4(+) (2)
- CD40 (2)
- CD46 (2)
- CD8 T-Zellen (2)
- CMV (2)
- CTLA-4 (2)
- Ceramide (2)
- Chemotaxis (2)
- Children (2)
- CpG-ODN (2)
- Cytomegalie-Virus (2)
- D665 (2)
- Demenz (2)
- Dendritic cell (2)
- Dopamin (2)
- EBV (2)
- Elite Controller (2)
- Epidemiologie (2)
- Foamy virus (2)
- GM-CSF (2)
- Glykoproteine (2)
- HAART (2)
- HAND (2)
- HHV-6 (2)
- HIVDR (2)
- Herpes (2)
- Homologe Rekombination (2)
- Human papillomavirus (2)
- Hybridvektor (2)
- IL1RA (2)
- ISGF3 (2)
- ISRE (2)
- Immunbiologie (2)
- Immunstimulation (2)
- Impfstoff (2)
- Inhibition (2)
- KDELR2 (2)
- KLRG1 (2)
- ME/CFS (2)
- MLR (2)
- Makrophagen (2)
- Matrix-Protein (2)
- Matrixproteine (2)
- Measles (2)
- Medicine (2)
- Memantin (2)
- Molekularbiologie (2)
- NK cells (2)
- Natürliche Killerzelle (2)
- PVM (2)
- Parkinson-Krankheit (2)
- Persistenz (2)
- Polyadenylierung (2)
- Polyoma-Virus (2)
- Polyomavirus WU (2)
- Proteasen (2)
- Proteine (2)
- Proteinkinase B (2)
- RNA (2)
- RNA interference (2)
- RNA polymerase II (2)
- RS-Virus (2)
- RSV (2)
- Regulatorische T-Zellen (2)
- Reverse Transkriptase (2)
- Rezeptor (2)
- Rheumatoide Arthritis (2)
- SLAM (2)
- SSPE (2)
- Sindbisvirus (2)
- Sphingolipide (2)
- Sphingomyelin (2)
- Spumaviruses (2)
- Staupevirus (2)
- T Zellen (2)
- T cell development (2)
- T cell receptors (2)
- T-Helferzellen (2)
- T-Lymphozyten-Rezeptor (2)
- T-Zell-Aktivierung (2)
- T-Zellrezeptor (2)
- TAB08 (2)
- TCR (2)
- TGF-BETA (2)
- Therapie (2)
- Thymus (2)
- Transkriptionsfaktor (2)
- VLA-1 (2)
- Virology (2)
- Virulenz (2)
- Zelldifferenzierung (2)
- Zelltod (2)
- Zentralnervensystem (2)
- Zytoskelett (2)
- acid ceramidase inhibitor ceranib-2 (2)
- activation (2)
- alpaca (2)
- antigen presentation (2)
- avidity (2)
- azidothymidine (2)
- bcl-2 (2)
- binding protein (2)
- bone marrow (2)
- butyrophilin (2)
- butyrophilin 3 (2)
- costimulation (2)
- cytokine secretion (2)
- cytokines (2)
- cytoskeleton (2)
- cytotoxic T cells (2)
- depression (2)
- domain (2)
- endothelial cells (2)
- expression (2)
- foamy viruses (2)
- gene regulation (2)
- genetics (2)
- glucocorticoid (2)
- glycoproteins (2)
- granzyme B (2)
- hemagglutinin (2)
- herpes simplex virus (2)
- hybrid vector (2)
- identification (2)
- immune suppression (2)
- immunologische Synapse (2)
- in-vivo (2)
- inflammation (2)
- lymph nodes (2)
- measels virus (2)
- mouse (2)
- multiple myeloma (2)
- neurodegeneration (2)
- neurovirulence (2)
- neutral sphingomyelinase-2 (2)
- oxidative stress (2)
- peripheral nervous system (2)
- plasma membrane (2)
- receptor (2)
- recombination (2)
- regulatory T-cells (2)
- regulatory t cells (2)
- resistance (2)
- retroviral vectors (2)
- retrovirus (2)
- sialic acid (2)
- signal transduction (2)
- signaltransduction (2)
- small interfering RNAs (2)
- sphingolipid (2)
- sphingosine kinase inhibitor SKI-II (2)
- therapy (2)
- toll-like receptors (2)
- transcription (2)
- translation (2)
- treatment (2)
- vaccination (2)
- viral infection (2)
- viral load (2)
- γδ T cell (2)
- 1,2-benzisothiazolinone (1)
- 2',7'-dichlorofluorescin (1)
- 3-Dioxygenase (1)
- 3-dioxygenase (1)
- 3C-like protease (1)
- 3C-like-Protease (1)
- 3D Ko-kulture (1)
- 3D cell culture (1)
- 3D-Modell (1)
- 5`-UTR (1)
- 60-nucleotide duplication (1)
- ABCG2 (1)
- ACH-2 (1)
- ADP-Ribose-1"-Phosphatase (1)
- ADP-Ribose-1"-phosphatase (1)
- AKT-signaling (1)
- ASM (1)
- ASM-Inhibition (1)
- ATP-adenosine triphosphate (1)
- ATRA (1)
- Acetylcystein (1)
- Actinomycetes (1)
- Activation (1)
- Adaptation (1)
- Adaptive cell transfer (1)
- Adenovirus 5 (1)
- Adhesion (1)
- Aktin (1)
- Aktivierung (1)
- Allergie (1)
- Alloreaktion (1)
- Alloreaktivität (1)
- Allotransplantation (1)
- Alpha therapy (1)
- Alternative (1)
- Alternative Strategien (1)
- Alzheimer’s disease (1)
- Aminobisphosphonat (1)
- Aminobisphosphonate (1)
- Anpassung (1)
- Anti-Gehirn Autoantikörper (1)
- Antibody (1)
- Antibody responses (1)
- Antigen (1)
- Antigen CD25 (1)
- Antigen CD3 (1)
- Antigen CD9 (1)
- Antigen CD95 (1)
- Antigen presentation (1)
- Antigenerkennung (1)
- Antigenpräsentation (1)
- Antigentherapie (1)
- Antikörper gegen N-Protein (1)
- Antikörperantworten (1)
- Antikörperescape (1)
- Antioxidantien (1)
- Antisense (1)
- Arteriosklerose (1)
- Arthritis (1)
- Aspergillus (1)
- Aspergillus fumigatus (1)
- Assembly (1)
- Atemwegsinfektionen (1)
- Atemwegskrankheit (1)
- Atherosklerose (1)
- Auto-antibodies (1)
- Autoantigen (1)
- Autoimmune diseases (1)
- Autophagie (1)
- Autophagy (1)
- B Zelle (1)
- B cell differentiation (1)
- B-2 (1)
- B-Cells (1)
- B-Lympho (1)
- B-Lymphozyten-Rezeptor (1)
- B-Zell-Lymphom (1)
- B-Zelldifferenzierung (1)
- B-Zelle (1)
- B-cell signaling (1)
- B-cells (1)
- B-zells (1)
- BBC3 (1)
- BCG (1)
- BCR (1)
- BK virus (1)
- BK-Virus (1)
- BTN (1)
- BTN2 (1)
- BTN2A1 (1)
- BTN3A1 (1)
- BZR (1)
- Bakterien (1)
- Bauchspeicheldrüsenkrebs (1)
- Baumwollrattenmodell (1)
- Bcl-2-Proteinfamilie (1)
- Bim (1)
- Biologie (1)
- Biomarker (1)
- Biomarkers (1)
- Blockade (1)
- Blood Brain Barrier (1)
- Blut-Hirn-Schranke (1)
- Blutbildendes Gewebe (1)
- Blutstammzelle (1)
- Boccavirus (1)
- Bone marrow transplantantation (1)
- Borna Disease Virus (1)
- Bowen’s disease, periungual (1)
- Braak (1)
- Brugia Malayi (1)
- Bruton Tyrosine Kinase (1)
- Bryophyta (1)
- Budding (1)
- Bystander (1)
- C-terminal domain (1)
- C. albicans (1)
- CCS (1)
- CD 8 (1)
- CD25+CD4+ regulatory T cells (1)
- CD28 Superagonisten (1)
- CD28 costimulation (1)
- CD28 superagonists (1)
- CD28-SA (1)
- CD28-Superagonist (1)
- CD28-superagonist (1)
- CD38 (1)
- CD39 (1)
- CD4 T-Zellen (1)
- CD4 Zellen (1)
- CD4 cells (1)
- CD4 positiv T cells (1)
- CD4(+) T-cells (1)
- CD4(+)CD25(+) (1)
- CD4+ (1)
- CD4+ T cells (1)
- CD4+-CTL (1)
- CD4\(^{+}\) T cells (1)
- CD4\(^{+}\) T helper cells (1)
- CD57 (1)
- CD73 (1)
- CD8 (1)
- CD8 Effektorfunktionen (1)
- CD8 Gedächtnisreaktionen (1)
- CD8 T cell (1)
- CD8 T-Zell-Subpopulation (1)
- CD8 T-cell subpopulation (1)
- CD8+ T cells (1)
- CD8+ T-Zellen (1)
- CD8+ T-cells (1)
- CD8+-CTL (1)
- CD9 (1)
- CD95 (1)
- CDV (1)
- CLEC16A (1)
- CNS infection (1)
- COVID‐19 (1)
- COVID‐19 vaccination (1)
- CRAC (1)
- CRISPR/Cas-Methode (1)
- CSF (1)
- CVID (1)
- Ca2+ (1)
- Calu-3 (1)
- Cancer (1)
- Candida (1)
- Capsidgen (1)
- Carcinogenese (1)
- Caspasen (1)
- Caspases (1)
- Cell migration (1)
- Cell signalling (1)
- Cerebrospinal fluid (CSF) (1)
- ChIP-seq (1)
- Chimäre <Biologie> (1)
- Chromatin (1)
- Citalopram (1)
- Collagenase (1)
- Common variable immunodeficiency (1)
- Coronaviral main protease (1)
- Coronavirale Hauptprotease (1)
- Costimulation (1)
- CpG-Inseln (1)
- Cytokine (1)
- Cytolyse (1)
- Cytolysis (1)
- Cytomegalovirus (1)
- Cytotoxicity (1)
- Cytotoxizität (1)
- DAPI staining (1)
- DAT (1)
- DC-SIGN (1)
- DC/T-Zell-Konjugate (1)
- DETC (1)
- DNA sequence (1)
- DNA transcription (1)
- DNA traps (1)
- DRAF1 (1)
- Deaminase (1)
- Dengue (1)
- Desaktivierung (1)
- Desaminase (1)
- Desaminierung (1)
- Desipramin (1)
- Diabetes Mellitus (1)
- Diabetes mellitus (1)
- Diabetes mellitus Typ 1 (1)
- Diagnostik (1)
- Disease genetics (1)
- Disease severity (1)
- Dolutegravir (1)
- Donor lymphocytes (1)
- Dopamin-Transporter (1)
- Dopamine transporter (1)
- Durchflusscytometrie (1)
- Dynabeads (1)
- EAAT (1)
- EIA (1)
- EMSA (1)
- ESCRT (1)
- ESCRT-System (1)
- EVER1 (1)
- EVER2 (1)
- Effektivität (1)
- Einfluss (1)
- Encephalomyelitis (1)
- Endogenes Ekzem (1)
- Endonucleasen (1)
- Endonuklease (1)
- Endothel (1)
- Endothelzelle (1)
- Endothelzellen (1)
- Enterovirus (1)
- Entzündung (1)
- Enzephalitis (1)
- Enzyme-linked immunosorbent assay (1)
- Epidemiology (1)
- Epithelzelle (1)
- Escherichia coli infections (1)
- Evaluation (1)
- Expression (1)
- Extracellular domain (1)
- Exzitotoxizität (1)
- Factor receptor (1)
- Falviviridae (1)
- Fanconi Anemia (1)
- Farnesyl Pyrophosphate Synthase (1)
- Farnesylpyrophosphatsynthase (FPPS) (1)
- Fibroblasten (1)
- Flt3L (1)
- Fluoreszenzaktivierter Zellsortierer (1)
- Flymphozyt (1)
- FoxP3 (1)
- Foxp3 (1)
- Friend Virus (1)
- Friend-Leukämievirus (1)
- Frühe Gene (1)
- Fusion (1)
- G glycoprotein (1)
- GBS (1)
- GDS (1)
- GFAP-Antikörper (1)
- GFAP-antibodies (1)
- GRP78 (1)
- Gag protein (1)
- Gag-Proteine (1)
- GagPol fusion protein (1)
- Gedächtniszellen (1)
- Gehirn (1)
- Gelretentionsanalyse (1)
- Gen (1)
- Gen notch (1)
- Gene Targeting (1)
- Gene therapy (1)
- Genetik (1)
- Genotyp (1)
- Genotypverteilung (1)
- Genregulation (1)
- Gentheraphie (1)
- Gentheraphy (1)
- German people (1)
- Germany (1)
- Gliafaserprotein (1)
- Gliotoxin (1)
- Glucocorticoid receptor (1)
- Glucocorticosteroidrezeptor (1)
- Glukocorticioid (1)
- Glukokortikoid Rezeptor (1)
- Glutamat (1)
- Glycoproteins (1)
- Golgi (1)
- Graft versus Tumor (1)
- Graft-versus-leukemia (1)
- Granzym A (1)
- Granzym B (1)
- Granzyme B (1)
- Grippe (1)
- Growth Arrest (1)
- Guillain-Barré-Syndrom (1)
- H-Protein (1)
- H-protein (1)
- HAND (HIV assoziierte neurologische Störungen) (1)
- HBMEC (1)
- HCMV (1)
- HCoV-229E (1)
- HERV (1)
- HHV 6 (1)
- HIV Drug resistance (1)
- HIV South Africa (1)
- HIV dementia (1)
- HIV diagnosis and management (1)
- HIV infections (1)
- HIV neurocognitive impairment (1)
- HIV-1 Vif (1)
- HIV-1 subtype AG (1)
- HIV-1-infected patients (1)
- HIV-1; subtype C; proviral plasmid; viral replication; resistance assays; Vpu; CD317; CD4 (1)
- HIV-Demenz (1)
- HIV-Infection (1)
- HIV-Subtyp (1)
- HIV-Vektor (1)
- HIV-associated neurocognitive disorder (HAND) (1)
- HIV-associated neurological disorders (1)
- HIV-assoziierte neurokognitive Störung (1)
- HIV-assoziierte neurokognitive Störung (HAND) (1)
- HIV-assoziierte neurologische Erkrankungen (1)
- HIV-infection (1)
- HIV-vector (1)
- HLA-DR (1)
- HTLV-I (1)
- HUVEC (1)
- Hamburg (1)
- Hantavirus (1)
- Helicase (1)
- Helikase (1)
- Hepatitis B (1)
- Herpes simplex (1)
- Herpes-simplex-Virus (1)
- Herpesviren (1)
- Herpesvirus (1)
- Herpesviruses (1)
- High-Capacity Adenovirus (1)
- Hitzestress (1)
- Homing (1)
- Hsp90 (1)
- Human Parechovirus (1)
- Human foamy virus bel-l transactivator; Expression in insect cells (1)
- Humane Parechoviren (1)
- Humorale Immunität (1)
- Hypnales (1)
- Hämagglutinin (1)
- ICP27 (1)
- ICP4 (1)
- IE3 (1)
- IFN-g (1)
- IFN-gamma (1)
- IFNAR (1)
- IL-12 (1)
- IL-1RA (1)
- IL-2 (1)
- IL-3 (1)
- IL-4 (1)
- IL‐10 (1)
- IRAK2-Mutation N333D (1)
- IRAK2-defiziente Zellen (1)
- Ibrutinib (1)
- IgG (1)
- Immature B cell (1)
- Immunactivation (1)
- Immune activation (1)
- Immunesupression (1)
- Immunfluoreszenz (1)
- Immunität <Medizin> (1)
- Immunofluorescence Assay (1)
- Immunofluoreszenztest (1)
- Immunological synapse (1)
- Immunosuppression (1)
- Immunpathogenese (1)
- Immunsupression (1)
- Immuntherapie (1)
- IncRNA (1)
- Indolamin 2 (1)
- Infectious disease (1)
- Infektionen (1)
- Influenza (1)
- Inhibitor (1)
- Inhibitorproteine (1)
- Integrase (1)
- Integrase inhibitor (1)
- Integration (1)
- Integrin (1)
- Integrine (1)
- Interaction (1)
- Interaktionsrezeptor (1)
- Interferon <alpha-> (1)
- Interferon gamma (1)
- Interferonantagonism (1)
- Interferonantagonismus (1)
- Interferone (1)
- Interferonrezeptor (1)
- Interleukin 1-beta (1)
- Interleukin 10 (1)
- Interleukin-1 Rezeptorantagonist (1)
- Isopentenyl pyrophosphate (IPP) (1)
- Isopentenyl-pyrophosphat (IPP) (1)
- Isoprenoid Synthesis (1)
- Isoprenoide (1)
- Isoprenoidsynthese (1)
- Isotyp (1)
- JC-Virus (1)
- JCV (1)
- JNK (1)
- JURKAT-Zelle (1)
- Jurkat cells (1)
- KI-Polyomavirus (1)
- KRAS (1)
- Kardiomyopathie (1)
- Karibisches Meer (1)
- Keimzentrumsreaktion (1)
- Kerinokeratosis papulosa (1)
- Killerzelle (1)
- Kinasen (1)
- Kind (1)
- Klammeraffen (1)
- Knockout <Molekulargenetik> (1)
- Knockout Mice (1)
- Knockout Mäuse (1)
- Kohlenstoff (1)
- Kongress (1)
- Korezeptor (1)
- Krebs <Medizin> (1)
- LAD (1)
- LEW rat (1)
- LEW-Ratte (1)
- LFA-1 (1)
- LIF (1)
- LTR (1)
- Lamivudin (1)
- Langerhans cells (1)
- Leber und Dünndarmtransplantation (1)
- Lehrbuch (1)
- Lentiviren (1)
- Lentivirus (1)
- Ligand (1)
- Liquor (1)
- Lithiumtherapie (1)
- Liver and Small Bowel Transplantation (1)
- Lungenentzündung (1)
- Lymphocytes (1)
- Lymphom (1)
- Lymphomgenese (1)
- MALT (1)
- MALT-Typ Lymphom (1)
- MALT-type lymphoma (1)
- MAO-Hemme (1)
- MCMV (1)
- MEK/ERK-signaling (1)
- MHC (1)
- MHC I (1)
- MHC II (1)
- MHC Kl. I (1)
- MHC Klasse I (1)
- MHC Klasse II (1)
- MHC class I (1)
- MHC-Molekül (1)
- MHC-molecule (1)
- MIF (1)
- MIR-155 (1)
- MMTV (1)
- MPO (1)
- MRI (1)
- MS (1)
- MV receptor (1)
- MV transcription (1)
- Macrophage (1)
- Magnetaktivierter Zellsortierer (1)
- Major depression (1)
- Major splice donor (1)
- Malawi (1)
- Malignancies (1)
- Marginalzone (1)
- Masern Virus (1)
- Masern-Virus (1)
- Masernvirus Inhibitoren (1)
- Masernvirus-Infektion (1)
- Matrix Protein (1)
- Measles Virus (1)
- Measles Virus release (1)
- Measles virus (1)
- Measlesvirus (1)
- Mechanismus (1)
- Melanin (1)
- Membrane fusion (1)
- Membranfusion (1)
- Memory-B-Zellen (1)
- Mesocestoides corti (1)
- Metalloproteinase (1)
- Mikroglia (1)
- Milch (1)
- Mineralocorticoid receptor (1)
- Mineralokortikoid Rezeptor (1)
- Mitochondria (1)
- Molekulargenetik (1)
- Molekularpathologie (1)
- Monoclonal Antibodies (1)
- Monocytes and macrophages (1)
- Monozytendifferenzierung (1)
- Moose (1)
- Morbillivirus (1)
- Motoneuron (1)
- Multiple myeloma (1)
- Multiple sclerosis (1)
- Multiples Myelom (1)
- Multiplex-PCR (1)
- Mutation (1)
- Mutationen (1)
- Mutationsrate (1)
- Mycobacterium tuberculosis (1)
- Myelin Basic Protein Promoter (1)
- Myeloid-derived suppressor cells (1)
- Myeloma (1)
- N-CAM (1)
- N-Protein (1)
- N-oleoyl serinol (1)
- NF-kappaB (1)
- NFAT (1)
- NFATc1 (1)
- NFKB (1)
- NK-Zellen (1)
- NKT (1)
- NKT Zellen (1)
- NKT cells (1)
- NMDA-Rezeptor (1)
- NOD Maus (1)
- NRF2 (1)
- Nail unit (1)
- Nanoröhre (1)
- Necrosis (1)
- Nectin4 (1)
- Neisseria meningitidis (1)
- Nekrose (1)
- Neuritis (1)
- Neurodegeneration (1)
- Neurografts (1)
- Neuromelanin (1)
- Neuroprotektion (1)
- Neurotoxizität (1)
- Neurovirulenz (1)
- Neuweltaffen (1)
- NfL (1)
- Nichtstrukturproteine (1)
- Norovirus (1)
- Notch1 (1)
- Nucleosidanaloga (1)
- Nucleotidanaloga (1)
- Nucleus (1)
- Nucleus accumbens (1)
- Nuklearfaktor Kappa B (1)
- OPN (1)
- Off-Label-Use (1)
- Osteopontin (1)
- Ovalbumin (1)
- Oxidativer Stress (1)
- PAR-CLIP (1)
- PARM (1)
- PBMC (1)
- PC61, anti-CD25-antibody (1)
- PC62, anti-CD25-Antiörper (1)
- PCI-32765 (1)
- PCLS (1)
- PCR (1)
- PFV (1)
- PKB (1)
- PKB/Akt (1)
- PKCζ, (1)
- PML (1)
- PO (1)
- PRDI-BF1 (1)
- PTPN22 (1)
- Paramyxoviridae (1)
- Paramyxovirose (1)
- Parkinson Disease (1)
- Parkinsonism (1)
- Parkinsons Disease (1)
- Particleassembly (1)
- Partikelreifung (1)
- Partikelzusammenbau (1)
- Parvoviren (1)
- Pathway (1)
- Peak Caller (1)
- Penetration (1)
- Peptidtherapie (1)
- Perforin (1)
- Phage Display (1)
- Picornaviren (1)
- Picornavirus (1)
- Placebo (1)
- Plasmazellen (1)
- Plusstrangsynthese (1)
- Pneumoviruses (1)
- Po (1)
- Polyadenylation (1)
- Polymerase chain reaction (1)
- Polymerase-Protein (1)
- Polymerase-Proteine (1)
- Polymerasen (1)
- Polymorphismus (1)
- Polyomavirus (1)
- Polyomavirus JC (1)
- Polypurintrakt (1)
- PrP (1)
- Pra1 (1)
- Praeklampsie (1)
- Prednisolone (1)
- Primaten (1)
- Priming (1)
- Primärer Immundefekt (1)
- Primärresistenz (1)
- Prion protein (1)
- Prion-Protein (1)
- Prionen (1)
- Prionkrankheit (1)
- ProCort (1)
- Prodigy (1)
- Prognose (1)
- Progression zu AIDS (1)
- Promotor (1)
- Protease (1)
- Proteaseinhibitor (1)
- Prototyp-Foamyviren (1)
- Pseudovirion (1)
- Putamen (1)
- Pädiatrie (1)
- R0 (1)
- RAG1 (1)
- REDD1 (1)
- RNA Interferenz (1)
- RNA export (1)
- RNA structure (1)
- RNA-Export (1)
- RNA-Interferenz (1)
- RNA-Virus (1)
- RNAi (1)
- RNS-Bindung (1)
- RNS-Viren (1)
- RQQ domain (1)
- RSV-A ON1 (1)
- RT-qPCR (1)
- RT1B (1)
- RT1D (1)
- Reaktivierung (1)
- Real time quantitative PCR (1)
- Regeneration (1)
- Regluation (1)
- Regulation (1)
- Regulation of protease activity (1)
- Regulatorische T Zellen (1)
- Regulatorische T-Lymphozyt (1)
- Regulatory T cells (1)
- Regulatory-cells (1)
- RelB (1)
- Replikationskomplex (1)
- Resistances (1)
- Respiratory Infection (1)
- Respiratory infection (1)
- Respiratory tract infection (1)
- Resplex (1)
- Restriktionsenzym (1)
- Retroviraler Vektor (1)
- Retroviren-Infektion (1)
- Retrovirus (1)
- Retroviruses (1)
- Reverse Transkription (1)
- Rheumatoid arthritis (1)
- Ribavirin (1)
- S-Segment (1)
- SARS-CoV-2 brain disorders (1)
- SARS‐CoV‐2 (1)
- SARS‐CoV‐2 infection (1)
- SFVmac (1)
- SIV (1)
- SLAM CDW150 (1)
- SLAM-Code (1)
- SLAM-code (1)
- STEMI (1)
- STIM1 (1)
- STIM2 (1)
- Salmo trutta fario (1)
- Salzstress (1)
- Saure Sphingomyelinase (1)
- ScN2a Zellen (1)
- ScN2a cells (1)
- Schwangerschaft (1)
- Schwämme (1)
- Scrapie (1)
- Screening (1)
- Screeningtest (1)
- Seahorse XF (1)
- Sekundärmetabolit (1)
- Selegilin (1)
- Sequenzanalyse (1)
- Sequenzierung (1)
- Serotonin-Reuptake-Hemmer (1)
- Serotonin-Wiederaufnahmehemmer (1)
- Sertralin (1)
- Sialylsäure (1)
- Siglecs (1)
- Signalkaskaden (1)
- Signaltransduction (1)
- Skint1 (1)
- Slow-Virus-Infektion (1)
- Sphingolipidstoffwechsel (1)
- Sphingomyelinase (1)
- Sphingosin-1-Phosphat (1)
- Sphingosine-1-phosphate (1)
- Sphingosine-1-phosphats (1)
- Spumavirus (1)
- Stammbaum (1)
- Stammzelltransplantation (1)
- Stromelysin (1)
- Subakute Krankheit (1)
- Substratspezifität (1)
- Subtyp C (1)
- Superagonist (1)
- Superagonistic antibody (1)
- Superantigen (1)
- Suppression (1)
- Syncytin (1)
- Synthese (1)
- Säugling (1)
- Südafrika (1)
- T Cells (1)
- T Lymphozyt (1)
- T Zell Selektion (1)
- T cell acute lymphoblastic leukemia (1)
- T cell homeostasis (1)
- T cell migration (1)
- T cell receptor (TCR) (1)
- T cell selection (1)
- T cell silencing (1)
- T cell suppression (1)
- T helper 1 cells (1)
- T helper cell responses (1)
- T- Zelle (1)
- T-ALL (1)
- T-Helpercells (1)
- T-Lymphopenie (1)
- T-Zell Entwicklung (1)
- T-Zell Homöostase (1)
- T-Zell-Expansion (1)
- T-Zell-Lymphom (1)
- T-Zellaktivierung (1)
- T-Zellentwicklung (1)
- T-Zellmigration (1)
- T-Zellrezeptor (TZR) (1)
- T-cell (1)
- T-cell migration (1)
- T-cell receptor (1)
- T-cell-expansion (1)
- T-cells (1)
- T-lymphopeny (1)
- T-zellen (1)
- T/B-Zellinteraktion (1)
- T/B-cell-interaction (1)
- T1D (1)
- TAMs (1)
- TCF1 (1)
- TCF12 (1)
- TCR signaling cascade (1)
- TCRb (1)
- TGN1412 (1)
- TH2-Typ Cytokine (1)
- TH2-type cytokine (1)
- TITL (1)
- TLR2 (1)
- TLR4 (1)
- TNF (1)
- TNG1412 (1)
- TRDV2 (1)
- TRGV9 (1)
- Tamoxifen (1)
- Targeted Therapies (1)
- Taufliege (1)
- Tconv (1)
- Template Switching (1)
- Th1 (1)
- Th1 cells (1)
- Th2 (1)
- Thymozyten (1)
- Tierversuch (1)
- Tissue engineering (1)
- Tolerance (1)
- Toll-like Rezeptor 4 (1)
- Toll-ähnliche Rezeptoren (1)
- Toxoplasma gondii (1)
- Tr1 (1)
- Transcription (1)
- Transgen (1)
- Transgene (1)
- Transgene Tiere (1)
- Transkription (1)
- Transmission (1)
- Tubulin (1)
- Tumor Microenvironment (1)
- Tumor-necrosis-factor (1)
- Tumorwachstum (1)
- Typ 1 Diabetes (1)
- Ubiquitin- Proteasomen- Weg (1)
- Ubiquitin-Protein-Ligase (1)
- Ubiquitination (1)
- Ubiquitinierung (1)
- Uganda (1)
- Unreife B-Zelle (1)
- Untertyp (1)
- VH-Mutationsanalysen (1)
- VH-mutations (1)
- Vaccination (1)
- Vaccine (1)
- Vakzine (1)
- Variables Immundefektsyndrom (1)
- Varicella zoster (1)
- Vektor (1)
- Vereinfachung (1)
- Vero E6 (1)
- Vg9Vd2 T Zellaktivierung (1)
- Vg9Vd2 T cell (1)
- Vgamma9Vdelta2 (1)
- Vietnam (1)
- Viktoriaseeregion (1)
- Viral infections (1)
- Virologische Synapse (1)
- Virostatikum (1)
- Virus-Transmission (1)
- Virus-Zell-Fusion (1)
- Virus-like particles (1)
- Virus-ähnliche Partikel (1)
- Virusanzucht (1)
- Virusinfection (1)
- Virusinfektionen (1)
- Virusnachweis (1)
- Viruzid (1)
- Vγ9Vδ2 (1)
- Vγ9Vδ2 T cell (1)
- WASp (1)
- WEHI 231 (1)
- WU-Polyomavirus (1)
- Wachstumsstopp (1)
- Waxy papulosis of childhood (1)
- Wiskott-Aldrich syndrome (1)
- Wue-1 (1)
- ZAP-70 (1)
- Zell Migration (1)
- Zell-Zell-Fusion (1)
- Zelladhesion (1)
- Zelladhäsion (1)
- Zellfusion (1)
- Zellkonjugation (1)
- Zellkultur (1)
- Zelloberfläche (1)
- Zellrezeptor (1)
- Zellskelett (1)
- Zelluläre Immunität (1)
- Zidovudin (1)
- Zytokine (1)
- Zytolyse (1)
- Zytoskelettreorganisation (1)
- acetylsalicylic acid (1)
- acid ceramidase (1)
- acquisition of host regulators (1)
- actin (1)
- actins (1)
- acute Graft versus Host Disease (1)
- acute graft-versus-host disease (1)
- acute heart failure (1)
- acute kidney injury (1)
- adaptive immune response (1)
- adenosine (1)
- adhesion (1)
- admission screening (1)
- adoptive transfer (1)
- adult (1)
- age groups (1)
- aging (1)
- allogeneic stem cell transplantation (1)
- alloreaction (1)
- alloreactivity (1)
- alpha-globin (1)
- alternative splicing (1)
- alternative strategies (1)
- alveoar echinococcosis (1)
- amplicon sequencing (1)
- anemia (1)
- anergy (1)
- angiogenesis (1)
- animal models (1)
- anthocyanin (1)
- anti- apoptotic Bcl-2 family member A1 (1)
- anti- apoptotisches Bcl-2 Familienmitglied A1 (1)
- anti-GFAP (1)
- anti-brain autoantibodies (1)
- anti-depressant drug (1)
- anti-hiv agents (1)
- anti-myocardial (1)
- anti-protease (1)
- anti-retroviral agents (1)
- antiapoptotic Bcl-2 family member A1 (1)
- antiapoptotisches Bcl-2 Familienmitglied A1 (1)
- antibodies against n-protein (1)
- antibody (1)
- antibodyescape (1)
- antidepressants (1)
- antigen therapy (1)
- antigen-B (1)
- antigen-specific (1)
- antigenic recall (1)
- antimicrobial resistance (1)
- antioxidants (1)
- antiretrovirals (1)
- antiviral activity (1)
- antiviral treatment (1)
- antivirale Substanzen (1)
- antivirals (1)
- anti‐SARS‐CoV‐2‐spike IgG (1)
- anxiety (1)
- aorta (1)
- aorta ring (1)
- arteriosclerosis (1)
- arthritis (1)
- aspirin (1)
- astaxanthin (1)
- atherosclerosis (1)
- atopische Deramtitis (1)
- attachment glycoprotein (1)
- autoantibodies (1)
- autoantibody (1)
- avidity testing (1)
- azapeptide nitriles (1)
- azido-ceramides (1)
- bacteria (1)
- bacterial expression (1)
- bacterial pathogens (1)
- bakterielle Expression (1)
- bilberry (1)
- binding analysis (1)
- biochemical assays (1)
- bioinformatic (1)
- black currant (1)
- black trout syndrome (1)
- blocking opsonization (1)
- blocking phagocytosis (1)
- brain (1)
- brain bank (1)
- brain pathology (1)
- brain stem (1)
- branch point (1)
- brown trout (1)
- budding (1)
- butyrophilin 2A1 (1)
- butyrophilins (1)
- cDC2 subset (1)
- calcium (1)
- calnexin (1)
- cancer microenvironment (1)
- canine (1)
- canine distemper virus (1)
- capsid gene (1)
- cardiac magnetic resonance imaging (1)
- cardiorespiratory centre (1)
- caveolin-1 (Cav-1) (1)
- cd28 superagonists (1)
- cell adhesion (1)
- cell cycle and cell division (1)
- cell death (1)
- cell differentiation (1)
- cell line specificity pyridyl indole carboxylates (1)
- cell line-specificity (1)
- cell membrane (1)
- cell membrane model (1)
- cell migration (1)
- cell-cell-Fusion (1)
- cell-cycle dependence (1)
- cells (1)
- cellular immunity (1)
- cellular receptor (1)
- cellular stress responses (1)
- central-nervous-system (1)
- ceramidase (1)
- cerebrospinal fluid (1)
- channel (1)
- characterization and analytical techniques (1)
- chemotaxis (1)
- chikungunya virus (1)
- child (1)
- children (1)
- cholera (1)
- cholesteryl ester (1)
- chondrogenesis (1)
- chromatin (1)
- chronic immune activation (1)
- chronic rhinosinusitis (1)
- chronical-infected cells (1)
- chronisch-infizierte Zellen (1)
- circulation patterns (1)
- cis-acting sequences (1)
- co-evolution (1)
- co-stimulation, (1)
- coevolution (1)
- cognitive dysfunction (1)
- collagenase (1)
- complement (1)
- complement factor H (1)
- complex (1)
- complex retrovirus (1)
- conversion (1)
- coreceptor (1)
- coronavirus (1)
- cotton rat (1)
- criteria (1)
- critically ill (1)
- cross-linking (1)
- cryptic peptides (1)
- cytokine release (1)
- cytokine release syndrome (1)
- cytokine responses (1)
- cytosceleton (1)
- cytoskeletal reorganisation (1)
- decay (1)
- defective ribosomal products (1)
- degradation (1)
- demyelination (1)
- dendritische Zelle (1)
- dendritische Zellen (1)
- dengue virus (1)
- dentritische Zellen (1)
- diacylglycerol (1)
- diagnostic (1)
- diet (1)
- differential diagnosis (1)
- differentiation (1)
- direct stimulation (1)
- direct-acting antivirals (1)
- direkte Stimulation (1)
- disease severity (1)
- distribution (1)
- diversity (1)
- dmrt1 (1)
- dna-binding protein (1)
- dogs (1)
- dopamine (1)
- drosophila melanogster (1)
- drug adherence (1)
- drug discovery (1)
- drug interactions (1)
- embryo (1)
- endonuclease (1)
- endothelial cell infection (1)
- enhance viral transcription (1)
- env leader protein (1)
- enzyme-linked immunoassays (1)
- enzymes (1)
- epicutaneous (1)
- epidemiology (1)
- epitope mapping (1)
- epitope specificity (1)
- epstein-barr virus (1)
- excitotoxicity (1)
- exclusion criteria (1)
- excretory-secretory (1)
- factor H (1)
- fibroblasts (1)
- fluorescence-activated cell sorting (1)
- fluoxetine (1)
- foamy (1)
- foamy retrovirus (1)
- foamyviruses (1)
- fungal infection (1)
- fusion (1)
- fusion and fission (1)
- gamma-interferon (1)
- gammadelta T Zelle (1)
- gammadelta T cel l (1)
- gammadelta T cells (1)
- gd T Zellen (1)
- gd T cells (1)
- gemischt (1)
- gemischte Lymphozytenreaktion (1)
- gene delivery (1)
- gene-expression (1)
- genetic conservation (1)
- genetic interference (1)
- genetic variability (1)
- genotype (1)
- germinal centre (1)
- glial damage (1)
- glial fibrillary acidic protein (1)
- glutamate (1)
- glycolipids (1)
- glycosphingolipids (1)
- granulosus (1)
- granzyme A (1)
- group B genotype (1)
- group-A (1)
- guidelines (1)
- hACE2 (1)
- hantavirus (1)
- healthcare workers (1)
- heart (1)
- heart failure (1)
- helicase (1)
- helminth infection (1)
- helminths (1)
- hematological disorders (1)
- hematopoietic stem cell (1)
- hepadnaviruses (1)
- heroine (1)
- herpes virus (1)
- heterolog (1)
- heterologous (1)
- high-capacity adenovirus (1)
- highly-active antiretroviral therapy (1)
- histones (1)
- homeostasis (1)
- homing (1)
- host shutoff (1)
- host-pathogen interactions (1)
- human behaviour (1)
- human bocavirus (1)
- human cytomegalovirus (HCMV) (1)
- human immunodeficiency virus (1)
- human peripheral blood (1)
- humans (1)
- hydatid disease (1)
- immediate early genes (1)
- immune cells (1)
- immune control (1)
- immune escape (1)
- immune modulation (1)
- immune neuromelanin (1)
- immune pathogenesis (1)
- immune response (1)
- immune therapy (1)
- immunisation (1)
- immunization (1)
- immuno suppression (1)
- immunoglobulin superfamily (1)
- immunologic tolerance (1)
- immunological synapse (1)
- immunomodulation (1)
- immunomodulatory (1)
- immunoprecipitation (1)
- immunosurveillance (1)
- immunotherapy (1)
- immunsuppression (1)
- immunsystem (1)
- immuntherapy (1)
- improves survival (1)
- in vitro culture (1)
- in vivo (1)
- indinavir (1)
- indoleamine 2 (1)
- inducible deletion (1)
- inducible nitric oxide synthase (1)
- induzierte regulatorische T-Zellen (1)
- infarction size (1)
- infected mice (1)
- infected-cell protein (1)
- infection control (1)
- infection spread (1)
- infectivity assays (1)
- influenza (1)
- influenza A virus (1)
- influenza virus (1)
- inhibitorisch (1)
- inhibitorische Rezeptoren (1)
- inhibitory (1)
- inhibitory receptors (1)
- injecting drug users (1)
- innate immune response (1)
- innate lymphoid cells (1)
- integration (1)
- integration site selection (1)
- interferon signaling (1)
- interferon γ (1)
- interleukin 1 receptor antagonist (1)
- interleukins (1)
- intraarticular (1)
- intraartikulär (1)
- invariant NKT cells (1)
- invariante NKT Zellen (1)
- isotype (1)
- kidneys (1)
- kinases (1)
- klinische Studie (1)
- komplexer Retrovirus (1)
- konventionelle CD4 T Zellen (1)
- large gene lists (1)
- larvae (1)
- latency (1)
- lethality rate (1)
- leukemia (1)
- lipids (1)
- liposome (1)
- lithium (1)
- long terminal repeat (1)
- longevity (1)
- luciferase assay (1)
- lymphocyte activation (1)
- lymphomagenesis (1)
- lymphomas (1)
- lyso-phospholipids (1)
- lytic infection (1)
- mRNA (1)
- mTORC1 (1)
- magnetic properties and materials (1)
- major depression (1)
- major histocompatibility complex (1)
- management (1)
- marginal zone (1)
- marine sponge (1)
- matrix protein (1)
- measles virus infection (1)
- mechanism (1)
- mediated suppression (1)
- medical (1)
- medical research (1)
- mematine (1)
- memory B cells (1)
- memory b cell (1)
- memory cells (1)
- meningococcal disease (1)
- mesenchymal stem cell (1)
- messenger RNA (1)
- metacestode vesicles (1)
- metalloproteinase (1)
- mevalonate pathway (1)
- miR-30 (1)
- miRNA (1)
- miRNA processing (1)
- miRNA target (1)
- miRNS (1)
- mice (1)
- microRNA (1)
- microbial mutation (1)
- microbiology (1)
- microglia (1)
- migration (1)
- milk (1)
- mitochondria (1)
- mixed (1)
- modulation of immune response (1)
- molecular biology (1)
- molecular characterization (1)
- molecular cloning (1)
- molecular epidemiology (1)
- molekulare Epidemiologie (1)
- monoclonal antibodies (1)
- monocyte (1)
- monocyte differentiation (1)
- moonlighting (1)
- morbillivirus (1)
- morbilliviruses (1)
- morphine (1)
- mortality (1)
- mothers (1)
- motif discovery (1)
- motifs (1)
- motility (1)
- mouse models (1)
- movement disorders (1)
- mukosale Immunantwort (1)
- multi-drug resistance (1)
- multihit targeting (1)
- multiple Sklerose (1)
- murine cytomegalovirus (MCMV) (1)
- murine model (1)
- mutant mice (1)
- mutation databases (1)
- mutationrate (1)
- mutations (1)
- mycobacteria (1)
- myelin (1)
- myeloid-derived suppressor cell (MDSC) (1)
- myeloid-derived suppressor cells (MDSC) (1)
- myeloid-derived suppressor cells (MDSCs) (1)
- myocardial infarction (1)
- n-protein (1)
- naloxone (1)
- nanobiocomposites (1)
- nanoparticles (1)
- nasal polyps (1)
- natürliche regulatorische T-Zellen (1)
- necrosis-factor-alpha (1)
- nervous-system (1)
- neurofilament light chain (1)
- neurografts (1)
- neuroinflammation (1)
- neuroinvasion (1)
- neurological symptoms/disorders (1)
- neutral sphingomyelinase (1)
- neutral sphingomyelinase 2 (1)
- new respiratory viruses (1)
- new world monkeys (1)
- next generation sequencing (1)
- nine-banded armadillo (1)
- non-canonical translation (1)
- non-nucleoside reverse transcriptase inhibitors (1)
- nucleosides (1)
- oligomers (1)
- opioids (1)
- ortholog (1)
- orthoreovirus (1)
- outpatients (1)
- ovarian cancer (1)
- oxidative phosphorylation (1)
- pH-regulated antigen 1 (Pra1) (1)
- pancreatic cancer (1)
- parainfluenza virus (1)
- parasitic diseases (1)
- parasitology (1)
- particle maturation (1)
- pathogenesis (1)
- pediatric infections (1)
- pediatrics (1)
- pellet culture (1)
- peptidomimetics (1)
- perforin (1)
- peripheral tolerance (1)
- persistierende Infektion (1)
- perspectives (1)
- phagocytosis (1)
- phosphoantigens (1)
- phospholipidosis (1)
- phylogenetische Analyse (1)
- piscine orthoreovirus (1)
- placental mammals (1)
- plasma cells (1)
- plasminogen (1)
- plus strand synthesis (1)
- pneumona virus (1)
- pol messenger-rna (1)
- polarization (1)
- poly(A) site usage (1)
- polyadenylation (1)
- polymicrobial sepsis (1)
- polymorphism (1)
- polyomavirus (1)
- polyomaviruses (1)
- population coverage (1)
- positive Selektion (1)
- positive selection (1)
- positive thymic selection (1)
- positive thymische Selektion (1)
- postmortem studies (1)
- pre-messenger RNA (1)
- precision-cut lung slices (1)
- prediction (1)
- preeclampsia (1)
- pregnancy (1)
- prevention (1)
- primary cells (1)
- primary infection (1)
- prion (1)
- prions (1)
- progression to AIDS (1)
- proliferation (1)
- proliferative darkening syndrome (1)
- promoter (1)
- promoter-proximal pausing (1)
- protease inhibitors (1)
- protein regulation and expression (1)
- protein sequencing (1)
- proteomic analysis (1)
- protocol (1)
- prototyp foamyviruses (1)
- pseudovirion (1)
- public health medicine (1)
- purine-rich element (1)
- purine-rich region (1)
- qualitative PCR (1)
- quality of life (1)
- quantitative real-time PCR (1)
- randomized controlled clinical trial (1)
- randomized controlled-trial (1)
- reactivation (1)
- real-time-PCR (1)
- recognition (1)
- recombinant proteins (1)
- regulation (1)
- regulatorische T Zelle (1)
- regulatory T cell (1)
- regulatory T cells (Treg) (1)
- regulatory protein ICP27 (1)
- remdesivir (1)
- replication complex (1)
- replikative senescence (1)
- respiratory syncytial virus (1)
- respiratory tract (1)
- restriction factors (1)
- retardeted virus (1)
- retargeted measles virus (1)
- retinal pigment epithelium (1)
- retinales Pigmentepithel (1)
- retroviral gene transfer (1)
- retroviral infection (1)
- retroviral proteins (1)
- retroviral vector (1)
- retrovirale Integrationsmuster (1)
- retrovirale Vektoren (1)
- retroviraler Gentransfer (1)
- retroviraler Vektor (1)
- retroviruses (1)
- reverse Genetik (1)
- reverse Transkription (1)
- reverse genetics (1)
- reverse transcriptase inhibitors (1)
- reverse transcriptase-polymerase chain reaction (1)
- reverse transcription (1)
- reverse-transcriptase (1)
- reverse-transcriptase inhibitors (1)
- rheumatoid arthritis (1)
- ribavirin (1)
- ribonuclease H (1)
- routine clinical-practice (1)
- s-segment (1)
- salicylic acid (1)
- saure Sphingomyelinase (1)
- scrapie (1)
- self-reactivity (1)
- sepsis (1)
- sequence (1)
- sequence databases (1)
- seroprevalence (1)
- serum (1)
- sex-determining gene (1)
- shock (1)
- siRNA (1)
- signalling cascades (1)
- simian foamy viruses (1)
- simplification (1)
- spezifisch (1)
- sphingomonads (1)
- sphingosine 1-phosphate (1)
- sphingosine kinase (1)
- spider monkey (1)
- spleen (1)
- splice regulation (1)
- splicing (1)
- splicing inhibition (1)
- spread (1)
- spumavirus (1)
- steady state (1)
- steady-state dendritic cells (1)
- sterol pathway (1)
- strains (1)
- stress (1)
- stress resistance (1)
- stroke (1)
- stromelysin (1)
- subacute sclerosing-panencephalitis (1)
- subgroup-B (1)
- substrate specifity (1)
- subviral particle release (1)
- superagonist (1)
- superagonistische Funktion (1)
- surface transport (1)
- surfactants (1)
- surveillance (1)
- t cell development (1)
- t cells (1)
- t(11;18)(q21;q21) (1)
- t-cell (1)
- t-cells (1)
- tanzania (1)
- template switching (1)
- terminal differentiation (1)
- terminal gag domain (1)
- terminale Differenzierung (1)
- testing strategy (1)
- th1 (1)
- th2 (1)
- the microtubule-organizing center (1)
- thermal stresses (1)
- thymocyte (1)
- tissue (1)
- tolerogenic dendritic cells (1)
- toxins (1)
- transcription factors (1)
- transcriptional profiling (1)
- transcriptional termination (1)
- transcriptional transactivator (1)
- transcriptomics (1)
- transcutaneous (1)
- transduction (1)
- transient regulatory T-cell targeting (1)
- transkriptioneller Transaktivator (1)
- transmembrane protein (1)
- tubulin (1)
- tumor (1)
- tumor associated macrophages (1)
- tumour immunology (1)
- type 1 (1)
- type 1 ICP27 (1)
- type I interferon (1)
- tyrosine (1)
- ubiquitin- proteasome- pathway (1)
- ultraviolet radiation (1)
- unwindase (1)
- vaccination and immunization (1)
- vaccine (1)
- vaccinia virus (1)
- vector (1)
- vero cells (1)
- vesicles (1)
- viral entry (1)
- viral epidemiology (1)
- viral miRNAs (1)
- viral microRNAs (1)
- viral pathology (1)
- viral replication (1)
- viral shedding (1)
- virale Penetration (1)
- virale Proteine (1)
- virological synapse (1)
- virulence (1)
- virus budding (1)
- virus entry (1)
- virus host interaction (1)
- virus reactivation (1)
- virus replication (1)
- virus transmission (1)
- virus vectors (1)
- virus-cell-Fusion (1)
- virus-induced encephalitis (1)
- viruses (1)
- vitamin-D-receptor (1)
- vivo (1)
- wild-type (1)
- world health organization (1)
- xxx (1)
- zelluläre Immunität (1)
- zytotoxisch (1)
- zytotoxische T-Zellen (1)
- α-synuclein-specific T cells (1)
- γδ T cells (1)
- γδ TCR (1)
Institute
- Institut für Virologie und Immunbiologie (424) (remove)
Sonstige beteiligte Institutionen
- Datenintegrationszentrum Würzburg (DIZ) (1)
- Hans-Knöll-Institut Jena (1)
- Interdisziplinäre Biomaterial- und Datenbank Würzburg (ibdw) (1)
- Interdisziplinäres Zentrum für Klinische Forschung (ZIKF), Würzburg (1)
- Joslin Diabetes Center (Harvard Medical School) (1)
- Joslin Diabetes Center, Harvard Medical School (1)
- Roche Diagnostics GmbH Penzberg (1)
- University of Stellenbosch, Division of Medical Virology (1)
- Universität Jena (1)
EU-Project number / Contract (GA) number
- 721016 (3)
- 101041177 (1)
- 249177 (1)
- 825575 (1)
- 955974 (1)
- CoG 721016–HERPES (1)
- ERC-2016-CoG 721016-HERPES (1)
1,25-dihydroxyvitamin D3 (1,25D3) was reported to induce premature organismal aging in fibroblast growth factor-23 (Fgf23) and klotho deficient mice, which is of main interest as 1,25D3 supplementation of its precursor cholecalciferol is used in basic osteoporosis treatment. We wanted to know if 1,25D3 is able to modulate aging processes on a cellular level in human mesenchymal stem cells (hMSC). Effects of 100 nM 1,25D3 on hMSC were analyzed by cell proliferation and apoptosis assay, beta-galactosidase staining, VDR and surface marker immunocytochemistry, RT-PCR of 1,25D3-responsive, quiescence-and replicative senescence-associated genes. 1,25D3 treatment significantly inhibited hMSC proliferation and apoptosis after 72 h and delayed the development of replicative senescence in long-term cultures according to beta-galactosidase staining and P16 expression. Cell morphology changed from a fibroblast like appearance to broad and rounded shapes. Long term treatment did not induce lineage commitment in terms of osteogenic pathways but maintained their clonogenic capacity, their surface marker characteristics (expression of CD73, CD90, CD105) and their multipotency to develop towards the chondrogenic, adipogenic and osteogenic pathways. In conclusion, 1,25D3 delays replicative senescence in primary hMSC while the pro-aging effects seen in mouse models might mainly be due to elevated systemic phosphate levels, which propagate organismal aging.
The role of regulatory T cells (Tregs) in bacterial sepsis remains controversial because antibody-mediated depletion experiments gave conflicting results. We employed DEREG mice (DEpletion of REGulatory T cells) and a caecal ligation and puncture model to elucidate the role of \(CD4^+Foxp3^+\) Tregs in sepsis. In DEREG mice natural Tregs can be visualized easily and selectively depleted by diphtheria toxin because the animals express the diphtheria toxin receptor and enhanced green fluorescent protein as a fusion protein under the control of the foxp3 locus. We confirmed rapid Treg-activation and an increased ratio of Tregs to Teffs in sepsis. Nevertheless, 24 h after sepsis induction, Treg-depleted and control mice showed equally strong inflammation, immune cell immigration into the peritoneum and bacterial dissemination. During the first 36 h of disease survival was not influenced by Treg-depletion. Later, however, only Treg-competent animals recovered from the insult. We conclude that the suppressive capacity of Tregs is not sufficient to control overwhelming inflammation and early mortality, but is a prerequisite for the recovery from severe sepsis.
Background
Anthocyanin-containing plant extracts and carotenoids, such as astaxanthin, have been well-known for their antiviral and anti-inflammatory activity, respectively. We hypothesised that a mixture of Ribes nigrum L. (Grossulariaceae) (common name black currant (BC)) and Vaccinium myrtillus L. (Ericaceae) (common name bilberry (BL)) extracts (BC/BL) with standardised anthocyanin content as well as single plant extracts interfered with the replication of Measles virus and Herpesviruses in vitro.
Methods
We treated cell cultures with BC/BL or defined single plant extracts, purified anthocyanins and astaxanthin in different concentrations and subsequently infected the cultures with the Measles virus (wild-type or vaccine strain Edmonston), Herpesvirus 1 or 8, or murine Cytomegalovirus. Then, we analysed the number of infected cells and viral infectivity and compared the data to non-treated controls.
Results
The BC/BL extract inhibited wild-type Measles virus replication, syncytia formation and cell-to-cell spread. This suppression was dependent on the wild-type virus-receptor-interaction since the Measles vaccine strain was unaffected by BC/BL treatment. Furthermore, the evidence was provided that the delphinidin-3-rutinoside chloride, a component of BC/BL, and purified astaxanthin, were effective anti-Measles virus compounds. Human Herpesvirus 1 and murine Cytomegalovirus replication was inhibited by BC/BL, single bilberry or black currant extracts, and the BC/BL component delphinidin-3-glucoside chloride. Additionally, we observed that BC/BL seemed to act synergistically with aciclovir. Moreover, BC/BL, the single bilberry and black currant extracts, and the BC/BL components delphinidin-3-glucoside chloride, cyanidin-3-glucoside, delphinidin-3-rutinoside chloride, and petunidin-3-galactoside inhibited human Herpesvirus 8 replication.
Conclusions
Our data indicate that Measles viruses and Herpesviruses are differentially susceptible to a specific BC/BL mixture, single plant extracts, purified anthocyanins and astaxanthin. These compounds might be used in the prevention of viral diseases and in addition to direct-acting antivirals, such as aciclovir.
Butyrophilin (BTN)–3A and BTN2A1 molecules control the activation of human Vγ9Vδ2 T cells during T cell receptor (TCR)-mediated sensing of phosphoantigens (PAg) derived from microbes and tumors. However, the molecular rules governing PAg sensing remain largely unknown. Here, we establish three mechanistic principles of PAg-mediated γδ T cell activation. First, in humans, following PAg binding to the intracellular BTN3A1-B30.2 domain, Vγ9Vδ2 TCR triggering involves the extracellular V-domain of BTN3A2/BTN3A3. Moreover, the localization of both protein domains on different chains of the BTN3A homo-or heteromers is essential for efficient PAg-mediated activation. Second, the formation of BTN3A homo-or heteromers, which differ in intracellular trafficking and conformation, is controlled by molecular interactions between the juxtamembrane regions of the BTN3A chains. Finally, the ability of PAg not simply to bind BTN3A-B30.2, but to promote its subsequent interaction with the BTN2A1-B30.2 domain, is essential for T-cell activation. Defining these determinants of cooperation and the division of labor in BTN proteins improves our understanding of PAg sensing and elucidates a mode of action that may apply to other BTN family members.
Both, jawless and jawed vertebrates possess three lymphocyte lineages defined by highly diverse antigen receptors: Two T‐cell‐ and one B‐cell‐like lineage. In both phylogenetic groups, the theoretically possible number of individual antigen receptor specificities can even outnumber that of lymphocytes of a whole organism. Despite fundamental differences in structure and genetics of these antigen receptors, convergent evolution led to functional similarities between the lineages. Jawed vertebrates possess αβ and γδ T‐cells defined by eponymous αβ and γδ T‐cell antigen receptors (TCRs). “Conventional” αβ T‐cells recognize complexes of Major Histocompatibility Complex (MHC) class I and II molecules and peptides. Non‐conventional T‐cells, which can be αβ or γδ T‐cells, recognize a large variety of ligands and differ strongly in phenotype and function between species and within an organism. This review describes similarities and differences of non‐conventional T‐cells of various species and discusses ligands and functions of their TCRs. A special focus is laid on Vγ9Vδ2 T‐cells whose TCRs act as sensors for phosphorylated isoprenoid metabolites, so‐called phosphoantigens (PAg), associated with microbial infections or altered host metabolism in cancer or after drug treatment. We discuss the role of butyrophilin (BTN)3A and BTN2A1 in PAg‐sensing and how species comparison can help in a better understanding of this human Vγ9Vδ2 T‐cell subset.
Background: Hypnales comprise over 50% of all pleurocarpous mosses. They provide a young radiation complicating phylogenetic analyses. To resolve the hypnalean phylogeny, it is necessary to use a phylogenetic marker providing highly variable features to resolve species on the one hand and conserved features enabling a backbone analysis on the other. Therefore we used highly variable internal transcribed spacer 2 (ITS2) sequences and conserved secondary structures, as deposited with the ITS2 Database, simultaneously. Findings: We built an accurate and in parts robustly resolved large scale phylogeny for 1,634 currently available hypnalean ITS2 sequence-structure pairs. Conclusions: Profile Neighbor-Joining revealed a possible hypnalean backbone, indicating that most of the hypnalean taxa classified as different moss families are polyphyletic assemblages awaiting taxonomic changes.
The adaptive immune system is known to provide highly specific and effective immunity against a broad variety of pathogens due to different effector cells. The most prominent are CD4+ T-cells which differentiate after activation into distinct subsets of effector and memory cells, amongst others T helper 1 (Th1) cells. We have recently shown that mouse as well as human Th1 cells depend on T cell receptor (TCR) signals concomitant with CD28 costimulation in order to secrete interferon (IFN) which is considered as their main effector function. Moreover, there is a class of anti-CD28 monoclonal antibodies that is able to induce T cell (re-)activation without concomitant TCR ligation. These so-called CD28-superagonists (CD28-SA) have been shown to preferentially activate and expand CD4+ Foxp3+ regulatory T (Treg) cells and thereby efficaciously conferring protection e.g. against autoimmune responses in rodents and non-human primates. Considering this beneficial effect, CD28-SA were thought to be of great impact for immunotherapeutic approaches and a humanized CD28-SA was subjected to clinical testing starting with a first-in-man trial in London in 2006. Unexpectedly, the volunteers experienced life-threatening side effects due to a cytokine release syndrome (CRS) that was unpredicted by the preclinical studies prior to the trial. Retrospectively, CD4+ memory T cells within the tissues were identified as source of pro-inflammatory cytokines released upon CD28-SA administration. This was not predicted by the preclinical testing indicating a need for more reliable and predictive animal models. Whether mouse CD4+ T cells are generally irresponsive to CD28-SA stimulation or rather the lack of a bona fide memory T cell compartment in cleanly housed specific-pathogen-free (SPF) mice is the reason why the rodent models failed to predict the risk for a CRS remained unclear. To provide SPF mice with a true pool of memory/effector T cells, we transferred in vitro differentiated TCR-transgenic OT-II Th1 cells into untreated recipient mice. Given that Treg cells suppress T cell activation after CD28- SA injection in vivo, recipients were either Treg-competent or Treg-deficient, wild type or DEREG mice, respectively. Subsequent CD28-SA administration resulted in induction of systemic pro-inflammatory cytokine release, dominated by IFN, that was observed to be much more pronounced and robust in Treg-deficient recipients. Employing a newly established in vitro system mirroring the in vivo responses to CD28-SA stimulation of Th1 cells revealed that antigen-presenting cells (APCs) amplify CD28-SAinduced IFN release by Th1 cells due to CD40/CD40L-interactions. Thus, these data are the first to show that mouse Th1 cells are indeed sensitive to CD28-SA stimulation in vivo and in vitro responding with strong IFN release accompanied by secretion of further pro-inflammatory cytokines, which is compatible with a CRS. In conclusion, this study will facilitate preclinical testing of immunomodulatory agents providing a mouse model constituting more “human-like” conditions allowing a higher degree of reliability and translationability.
Background:
The foamy viral genome encodes four central purine-rich elements localized in the integrase-coding region of pol. Previously, we have shown that the first two of these RNA elements (A and B) are required for protease dimerization and activation. The D element functions as internal polypurine tract during reverse transcription. Peters et al., described the third element (C) as essential for gag expression suggesting that it might serve as an RNA export element for the unspliced genomic transcript.
Results:
Here, we analysed env splicing and demonstrate that the described C element composed of three GAA repeats known to bind SR proteins regulates env splicing, thus balancing the amount of gag/pol mRNAs. Deletion of the C element effectively promotes a splice site switch from a newly identified env splice acceptor to the intrinsically strong downstream localised env 3′ splice acceptor permitting complete splicing of almost all LTR derived transcripts. We provide evidence that repression of this env splice acceptor is a prerequisite for gag expression. This repression is achieved by the C element, resulting in impaired branch point recognition and SF1/mBBP binding. Separating the branch point from the overlapping purine-rich C element, by insertion of only 20 nucleotides, liberated repression and fully restored splicing to the intrinsically strong env 3′ splice site. This indicated that the cis-acting element might repress splicing by blocking the recognition of essential splice site signals.
Conclusions:
The foamy viral purine-rich C element regulates splicing by suppressing the branch point recognition of the strongest env splice acceptor. It is essential for the formation of unspliced gag and singly spliced pol transcripts.
A Review of the Multipronged Attack of Herpes Simplex Virus 1 on the Host Transcriptional Machinery
(2021)
During lytic infection, herpes simplex virus (HSV) 1 induces a rapid shutoff of host RNA synthesis while redirecting transcriptional machinery to viral genes. In addition to being a major human pathogen, there is burgeoning clinical interest in HSV as a vector in gene delivery and oncolytic therapies, necessitating research into transcriptional control. This review summarizes the array of impacts that HSV has on RNA Polymerase (Pol) II, which transcribes all mRNA in infected cells. We discuss alterations in Pol II holoenzymes, post-translational modifications, and how viral proteins regulate specific activities such as promoter-proximal pausing, splicing, histone repositioning, and termination with respect to host genes. Recent technological innovations that have reshaped our understanding of previous observations are summarized in detail, along with specific research directions and technical considerations for future studies.
Foamyviren (FVs) sind die genetisch stabilsten Viren der Retrovirus-Familie. Dies steht im Gegensatz zur Fehlerrate, die für die rekombinante FV Reverse Transkriptase (RT) gefunden wurde. Um die Genauigkeit der FV Genomreplikation in vivo zu ermitteln, analysierten wir das Auftreten von Mutationen nach FV-Vektortransfer in einer einzigen Replikationsrunde. Die Sequenzanalyse von mehr als 90000 Nukleotiden ergab 39 Mutationen. Dies entspricht einer Fehlerrate von ungefähr 4 x 10-4 pro Base und Replikationszyklus, wobei alle Mutationen Transitionen von G zu A waren. Eine schwache Expression von APOBEC-Enzymen in den vektorproduzierenden Zellen konnte als wahrscheinlichste Ursache für diesen Typ an Mutationen nachgewiesen werden. Das akzessorische FV Bet Protein wirkt APOBEC entgegen. Kotransfektion von Zellen mit einem bet-Expressionsplasmid resultierte in einer signifikanten Reduktion an Mutationen bei über 170000 zusätzlich sequenzierten Basen. Zwei Mutationen konnten nicht der APOBEC-Aktivität zugeschrieben werden, deshalb postulieren wir eine idealisierte FV-Mutationsrate von angenähert 7,5 x 10-6 pro Base und Replikationszyklus. Im Gegensatz zu in vitro-Analysen wurde nur eine einzige Deletion und keine Insertion bei mehr als 260000 sequenzierten Basen identifiziert. Die Analyse der Rekombinationsrate von FV-Vektorgenomen ergab mehr als ein zusätzliches Template-Switching-Ereignis pro reverser Transkription. Wir konnten auch zeigen, dass ein bestimmtes FV-Partikel in der Lage zum Crosstransfer eines heterologen FV-Genoms ist, jedoch mit einer reduzierten Effizienz als bei Verwendung des homologen Vektors. Zusammenfassend zeigen unsere Ergebnisse einerseits, dass das Kopieren des FV-Genoms mit höherer Genauigkeit geschieht als bisher angenommen, auf der anderen Seite ist Rekombination bei FV-Genomen wahrscheinlich.
Background
Measles virus (MV) causes T cell suppression by interference with phosphatidylinositol-3-kinase (PI3K) activation. We previously found that this interference affected the activity of splice regulatory proteins and a T cell inhibitory protein isoform was produced from an alternatively spliced pre-mRNA.
Hypothesis
Differentially regulated and alternatively splice variant transcripts accumulating in response to PI3K abrogation in T cells potentially encode proteins involved in T cell silencing.
Methods
To test this hypothesis at the cellular level, we performed a Human Exon 1.0 ST Array on RNAs isolated from T cells stimulated only or stimulated after PI3K inhibition. We developed a simple algorithm based on a splicing index to detect genes that undergo alternative splicing (AS) or are differentially regulated (RG) upon T cell suppression.
Results
Applying our algorithm to the data, 9% of the genes were assigned as AS, while only 3% were attributed to RG. Though there are overlaps, AS and RG genes differed with regard to functional regulation, and were found to be enriched in different functional groups. AS genes targeted extracellular matrix (ECM)-receptor interaction and focal adhesion pathways, while RG genes were mainly enriched in cytokine-receptor interaction and Jak-STAT. When combined, AS/RG dependent alterations targeted pathways essential for T cell receptor signaling, cytoskeletal dynamics and cell cycle entry.
Conclusions
PI3K abrogation interferes with key T cell activation processes through both differential expression and alternative splicing, which together actively contribute to T cell suppression.
Acetylsalicylic acid and salicylic acid inhibit SARS-CoV-2 replication in precision-cut lung slices
(2022)
Aspirin, with its active compound acetylsalicylic acid (ASA), shows antiviral activity against rhino- and influenza viruses at high concentrations. We sought to investigate whether ASA and its metabolite salicylic acid (SA) inhibit SARS-CoV-2 since it might use similar pathways to influenza viruses. The compound-treated cells were infected with SARS-CoV-2. Viral replication was analysed by RTqPCR. The compounds suppressed SARS-CoV-2 replication in cell culture cells and a patient-near replication system using human precision-cut lung slices by two orders of magnitude. While the compounds did not interfere with viral entry, it led to lower viral RNA expression after 24 h, indicating that post-entry pathways were inhibited by the compounds.
Aims
It has been hypothesized that cardiac decompensation accompanying acute heart failure (AHF) episodes generates a pro-inflammatory environment boosting an adaptive immune response against myocardial antigens, thus contributing to progression of heart failure (HF) and poor prognosis. We assessed the prevalence of anti-myocardial autoantibodies (AMyA) as biomarkers reflecting adaptive immune responses in patients admitted to the hospital for AHF, followed the change in AMyA titres for 6 months after discharge, and evaluated their prognostic utility.
Methods and results
AMyA were determined in n = 47 patients, median age 71 (quartiles 60; 80) years, 23 (49%) female, and 24 (51%) with HF with preserved ejection fraction, from blood collected at baseline (time point of hospitalization) and at 6 month follow-up (visit F6). Patients were followed for 18 months (visit F18). The prevalence of AMyA increased from baseline (n = 21, 45%) to F6 (n = 36, 77%; P < 0.001). At F6, the prevalence of AMyA was higher in patients with HF with preserved ejection fraction (n = 21, 88%) compared with patients with reduced ejection fraction (n = 14, 61%; P = 0.036). During the subsequent 12 months after F6, that is up to F18, patients with newly developed AMyA at F6 had a higher risk for the combined endpoint of death or rehospitalization for HF (hazard ratio 4.79, 95% confidence interval 1.13–20.21; P = 0.033) compared with patients with persistent or without AMyA at F6.
Conclusions
Our results support the hypothesis that AHF may induce patterns of adaptive immune responses. More studies in larger populations and well-defined patient subgroups are needed to further clarify the role of the adaptive immune system in HF progression.
Background
Ovarian cancer (OvCA) tissues show abundant expression of the ectonucleotidases CD39 and CD73 which generate immunomodulatory adenosine, thereby inhibiting cytotoxic lymphocytes. Little, however, is known about the effect of adenosine on myeloid cells. Considering that tumor associated macrophages (TAM) and myeloid-derived suppressor cells (MDSC) constitute up to 20 % of OvCA tissue, we investigated the effect of adenosine on myeloid cells and explored a possible contribution of myeloid cells to adenosine generation in vitro and ex vivo.
Methods
Monocytes were used as human blood-derived myeloid cells. After co-incubation with SK-OV-3 or OAW-42 OvCA cells, monocyte migration was determined in transwell assays. For conversion into M2-polarized “TAM-like” macrophages, monocytes were co-incubated with OAW-42 cells. Ex vivo TAMs were obtained from OvCA ascites. Macrophage phenotypes were investigated by intracellular staining for IL-10 and IL-12. CD39 and CD73 expression were assessed by FACS analysis both on in vitro-induced TAM-like macrophages and on ascites-derived ex situ-TAMs. Myeloid cells in solid tumor tissue were analyzed by immunohistochemistry. Generation of biologically active adenosine by TAM-like macrophages was measured in luciferase-based reporter assays. Functional effects of adenosine were investigated in proliferation-experiments with CD4+ T cells and specific inhibitors.
Results
When CD39 or CD73 activity on OvCA cells were blocked, the migration of monocytes towards OvCA cells was significantly decreased. In vivo, myeloid cells in solid ovarian cancer tissue were found to express CD39 whereas CD73 was mainly detected on stromal fibroblasts. Ex situ-TAMs and in vitro differentiated TAM-like cells, however, upregulated the expression of CD39 and CD73 compared to monocytes or M1 macrophages. Expression of ectonucleotidases also translated into increased levels of biologically active adenosine. Accordingly, co-incubation with these TAMs suppressed CD4+ T cell proliferation which could be rescued via blockade of CD39 or CD73.
Conclusion
Adenosine generated by OvCA cells likely contributes to the recruitment of TAMs which further amplify adenosine-dependent immunosuppression via additional ectonucleotidase activity. In solid ovarian cancer tissue, TAMs express CD39 while CD73 is found on stromal fibroblasts. Accordingly, small molecule inhibitors of CD39 or CD73 could improve immune responses in ovarian cancer.
Transcription describes the process of converting the information contained in DNA into RNA. Although, tremendous progress has been made in recent decades to uncover this complex mechanism, it is still not fully understood. Given the advances and reduction in cost of high-throughput sequencing experiments, more and more data have been generated to help elucidating this complex process. Importantly, these sequencing experiments produce massive amounts of data that are incomprehensible in their raw form for humans. Further, sequencing techniques are not always 100% accurate and are subject to a certain degree of variability and, in special cases, they might introduce technical artifacts. Thus, computational and statistical methods are indispensable to uncover the information buried in these datasets.
In this thesis, I worked with multiple high throughput datasets from herpes simplex virus 1 (HSV-1) and human cytomegalovirus (HCMV) infections. During the last decade, it has became clear that a gene might not have a single, but multiple sites at which transcription initiates. These multiple transcription start sites (TiSS) demonstrated to have regulatory effects on the gene itself depending on which TiSS is used. Specialized experimental approaches were developed to help identify TiSS (TiSS-profiling). In order to facilitate the identification of all potential TiSS that are used for cell type- and condition-specific transcription, I developed the tool iTiSS. By using a new general enrichment-based approach to predict TiSS, iTiSS proved to be applicable in integrated studies and made it less prone to false positives compared to other TiSS-calling tools. Another improvement in recent years was made in metabolic labeling experiments such as SLAM-seq. Here, they removed the time consuming and laborious step of physically separating new from old RNA in the samples. This was achieved by inducing specific nucleotide conversions in newly synthesized RNA that are later visible in the data. Consequently, the separation of new and old RNA is now done computationally and, hence, tools are needed that accurately quantify these fold-changes. My second tool that I developed, called GRAND-SLAM proved to be capable to accomplish this task and outperform competing programs. As both of my tools, iTiSS and GRAND-SLAM are not specifically tailored to my own goals, but could also facilitate the research of other groups in this field, I made them publicly available on GitHub.
I applied my tools to datasets generated in our lab as well as to publicly available data sets from HSV-1 and HCMV, respectively. For HSV-1, I was able to predict and validate TiSS with nucleotide precision using iTiSS. This has lead to the most comprehensive annotation for HSV-1 to date, which now serves as the fundamental basis of any future transcriptomic research on HSV-1. By combining both my tools, I was further able to uncover parts of the highly complex gene kinetics in HCMV and to resolve the limitations caused by the densely packed genome of HCMV.
With the ever-increasing advances in sequencing techniques and their decrease in cost, the amounts of data produced will continue to rise massively in the future. Additionally, more and more specialized omics approaches are appearing, calling for new tools to leverage their full information potential. Consequently, it has become apparent that specialized computational tools such as iTiSS and GRAND-SLAM are needed and will become an essential and indispensable part of the analysis.
The role of the thymus in the pathogenesis of simian acquired immunodeficiency syndrome was investigated in 18 juvenile rhesus monkeys (Macaca mulatta). The thymus was infected from the first week post-SIVmac inoculation, but the amount of virus-positive cells was very low « 1 in 1 04 T cells) as demonstrated by polymerase chain reaction and in situ hybridization. First morphological alteration was a narrowing of the cortex at 12 and 24 wpi. Morphometry revealed no increase of pyknotic T cells but a decrease of the proliferation rate andflow cytometry showed a reduction of the immature \(CD4^+/CD8^+\) double-positive T cells. Ultrastructural analysis revealed vacuolization, shrinkage, andfinally cytolysis of the cortical epithelial cells and the interdigitating dendritic cells. Immunofluorescence staining exhibited a widespread loss of cortical epithelial cells. This damage to the thymic microenvironment could explain the breakdown of the intrathymic T cell proliferation. It preceded fully developed simian acquired immunodeficiency syndrome and is therefore considered to play a major role in its pathogenesis.
In invertebrates, small interfering RNAs are at the vanguard of cell-autonomous antiviral immunity. In contrast, antiviral mechanisms initiated by interferon (IFN) signaling predominate in mammals. Whilst mammalian IFN-induced miRNA are known to inhibit specific viruses, it is not known whether host-directed microRNAs, downstream of IFN-signaling, have a role in mediating broad antiviral resistance. By performing an integrative, systematic, global analysis of RNA turnover utilizing 4-thiouridine labeling of newly transcribed RNA and pri/pre-miRNA in IFN-activated macrophages, we identify a new post-transcriptional viral defense mechanism mediated by miR-342-5p. On the basis of ChIP and site-directed promoter mutagenesis experiments, we find the synthesis of miR-342-5p is coupled to the antiviral IFN response via the IFN-induced transcription factor, IRF1. Strikingly, we find miR-342-5p targets mevalonate-sterol biosynthesis using a multihit mechanism suppressing the pathway at different functional levels: transcriptionally via SREBF2, post-transcriptionally via miR-33, and enzymatically via IDI1 and SC4MOL. Mass spectrometry-based lipidomics and enzymatic assays demonstrate the targeting mechanisms reduce intermediate sterol pathway metabolites and total cholesterol in macrophages. These results reveal a previously unrecognized mechanism by which IFN regulates the sterol pathway. The sterol pathway is known to be an integral part of the macrophage IFN antiviral response, and we show that miR-342-5p exerts broad antiviral effects against multiple, unrelated pathogenic viruses such Cytomegalovirus and Influenza A (H1N1). Metabolic rescue experiments confirm the specificity of these effects and demonstrate that unrelated viruses have differential mevalonate and sterol pathway requirements for their replication. This study, therefore, advances the general concept of broad antiviral defense through multihit targeting of a single host pathway.
About 1–5% of human blood T cells are Vγ9Vδ2 T cells. Their hallmark is the expression of T cell antigen receptors (TCR) whose γ-chains contain a rearrangement of Vγ9 with JP (TRGV9JP or Vγ2Jγ1.2) and are paired with Vδ2 (TRDV2)-containing δ-chains. These TCRs respond to phosphoantigens (PAg) such as (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP), which is found in many pathogens, and isopentenyl pyrophosphate (IPP), which accumulates in certain tumors or cells treated with aminobisphosphonates such as zoledronate. Until recently, these cells were believed to be restricted to primates, while no such cells are found in rodents. The identification of three genes pivotal for PAg recognition encoding for Vγ9, Vδ2, and butyrophilin (BTN) 3 in various non-primate species identified candidate species possessing PAg-reactive Vγ9Vδ2 T cells. Here, we review the current knowledge of the molecular basis of PAg recognition. This not only includes human Vγ9Vδ2 T cells and the recent discovery of BTN2A1 as Vγ9-binding protein mandatory for the PAg response but also insights gained from the identification of functional PAg-reactive Vγ9Vδ2 T cells and BTN3 in the alpaca and phylogenetic comparisons. Finally, we discuss models of the molecular basis of PAg recognition and implications for the development of transgenic mouse models for PAg-reactive Vγ9Vδ2 T cells.
Analyse der Expression und möglicher signalinduzierender Eigenschaften des CD1d-Moleküls der Ratte
(2010)
Wie MHC Klasse I und II-Moleküle präsentieren CD1d-Moleküle dem TCR Antigene, allerdings Lipide und Glykolipide und nicht Proteinfragmente. Die Entdeckung der massiven TH1- und TH2-Zytokinproduktion von Typ I-NKT-Zellen nach CD1d-vermittelter Erkennung von α-Galactosylceramid, einem aus dem Meeresschwamm gewonnenen Glykosphingolipid, weckte großes Interesse an ihrem immunregulatorischen Potential und ihrem möglichen Nutzen für neue Immun- und Tumortherapien. Um die Funktion und die Bedeutung von CD1d besser zu verstehen, wurden in dieser Arbeit die Expressionslevel der lymphatischen Gewebe der Ratte und der Maus untersucht. Hierfür wurden die neu generierten monoklonalen Antikörper 232 und 58/4 verwendet, die die CD1d-Moleküle von Ratte und Maus binden und so den direkten Vergleich beider Spezies ermöglichen. Sowohl die isolierten Zellen des Thymus und der Milz als auch des Lymphknotens waren in der LEW- und F344-Ratte sowie in der BALB/c-Maus schwach bis stark CD1d positiv. In der LEW-Ratte und in der F344-Ratte wiesen jeweils ca. 18% der Milzzellen eine vergleichsweise erhöhte CD1d-Expression auf. Dabei handelte es sich in erster Linie um Marginalzonen-B-Zellen. Bestimmte Subpopulationen der Dendritischen Zellen und vermutlich Makrophagen stellten die restlichen CD1d stark positiven Populationen dar. Nur ca. 2% der isolierten Zellen der Lymphknoten der LEW-Ratte waren stark CD1d positiv, wohingegen der LEW-Thymus gemäß dem noch geringeren Anteil an APC kaum Zellen mit erhöhter CD1d-Expression enthielt. In der BALB/c-Maus war der Anteil CD1d stark positiver Milzzellen mit 4% deutlich geringer als in der LEW- oder F344-Milz. Abgesehen von MZ-B-Zellen konnten in der Maus kaum Populationen mit starker CD1d-Expression in den verschiedenen Färbungen festgestellt werden. Demnach stellt CD1d sowohl in der Ratte als auch in der Maus einen guten Marker für MZ-B-Zellen dar. Demgegenüber zeigten vereinzelt kleine Populationen der Milz, des Lymphknotens und des Thymus beider Spezies eine verminderte oder gar keine CD1d-Expression. Zur Analyse möglicher signalinduzierender Eigenschaften der verschiedenen Anti- CD1d-Antikörper wurden ihre Effekte auf rCD1d+ Transduktanten und primäre Zellen untersucht. 58/4 konnte im Gegensatz zu 232 spezifisch über Bindung an Ratten- CD1d Zelltod und Aggregatbildung in Tumor-B-Zellen des Menschen und der Maus, aber nicht in Tumor-T-Zellen, induzieren. Der zytoplasmatische Schwanz der CD1d-Moleküle scheint an der Aggregatbildung beteiligt zu sein. Die Bindung von 58/4 oder 232 führte in überlebenden rCD1d+ Raji-Zellen zu einer ähnlich starken Internalisierung der CD1d-Moleküle. Während nach 5-stündiger Inkubation mit 232 und erneuter CD1d-Färbung wieder die vorherige CD1d- Expression festgestellt wurde, konnte nach Inkubation mit 58/4 eine bleibende Herunterregulierung beobachtet werden. Folglich bewirkte 58/4 ein anderes bzw. stärkeres Signal in den Zellen als 232. Diese Beobachtungen stützen die Signaltransduktion als mögliche weitere Funktion der CD1d-Moleküle neben der Antigenpräsentation und definieren die monoklonalen Antikörper 232 und 58/4 als nützliche Werkzeuge für weitere Studien zur Analyse der molekularen Mechanismen der CD1d-vermittelten Signaltransduktion. Das Verständnis solcher Mechanismen bildet wiederum die Grundlage für die Entwicklung neuer Therapien z. B. zur Eliminierung CD1d exprimierender Tumore.